Advertisement

Topics

Apricus mulling strategic options after FDA meeting

03:36 EDT 16 Apr 2018 | Reuters

(Reuters) - Drugmaker Apricus Biosciences Inc said on Monday it was considering strategic options after the U.S. Food and Drug Administration told it to develop a new formula for its erectile dysfunction cream Vitaros.

Original Article: Apricus mulling strategic options after FDA meeting

NEXT ARTICLE

More From BioPortfolio on "Apricus mulling strategic options after FDA meeting"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Erectile Dysfunction
Erectile dysfunction (ED or impotence) is the inability to get and maintain an erection that is sufficient for satisfactory sexual intercourse, and affects half of all men between the ages of 40 to 70. The causes of ED can be both physical and psycholo...